Results of a 12-month follow-up of patients with type 2 diabetes mellitus after hospitalization with COVID-19: gliclazide MR use in the hospital and metabolic status at the posthospital stage

T. A. Nekrasova; L. G. Strongin; D. V. Belikina; E. S. Malysheva; A. A. Nekrasov

doi:10.14341/DM13003-10222

For citations:

Nekrasova T.A., Strongin L.G., Belikina D.V., Malysheva E.S., Nekrasov A.A. Results of a 12-month follow-up of patients with type 2 diabetes mellitus after hospitalization with COVID-19: gliclazide MR use in the hospital and metabolic status at the posthospital stage. Diabetes mellitus. 2023;26(3):252-261. (In Russ.) https://doi.org/10.14341/DM13003

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Diabetes mellitus

For citations:

Cookies policy